Diagnosing Still's Disease: Latest Guidelines
Primary Diagnostic Approach
The 2024 EULAR/PReS guidelines establish that Still's disease diagnosis requires recognition of four cardinal features using operational definitions, and critically, arthritis is NOT mandatory for diagnosis—arthralgia alone is sufficient. 1
Core Diagnostic Criteria (Operational Definitions)
The following four features should be systematically assessed 1:
1. Fever Pattern
- Temperature ≥39°C (102.2°F) for at least 7 days 1
- Characteristic spiking pattern (quotidian or double-quotidian) 1
- This is the most consistent feature and should raise immediate suspicion 1
2. Skin Manifestations
- Salmon-pink (erythematous) rash that is transient and evanescent 1
- Typically coincides with fever spikes 1
- Preferentially involves the trunk 1
- Other rash patterns (urticarial) may be consistent with diagnosis 1
- Important caveat: The rash may be challenging to identify on darker skin tones 1
3. Musculoskeletal Involvement
- Arthralgia or myalgia is sufficient for diagnosis 1
- Overt arthritis is supportive but NOT necessary 1
- Arthritis typically appears later with a median delay of 1 month after disease onset (range 0 to several months) 1
- The 2024 guidelines explicitly state that requiring arthritis leads to unnecessary and potentially deleterious diagnostic delays 1
4. Laboratory Evidence of High Inflammation
- Neutrophilic leukocytosis 1
- Elevated ESR and serum CRP 1
- Elevated ferritin (typically markedly elevated) 1
- Additional supportive findings: increased platelet count, fibrinogen, and D-dimers 1
Classification Criteria to Guide Diagnosis
The Yamaguchi criteria remain the most validated tool, tested in both children and adults with high sensitivity 1:
- These criteria do NOT require arthritis for diagnosis, aligning with current understanding 1
- While not specifically developed for diagnostic ascertainment, classification criteria help clinicians identify the disease 1
- The diagnosis remains one of exclusion after ruling out infectious, neoplastic, and autoimmune disorders 1, 2
Advanced Biomarkers (When Available)
Marked elevation of serum IL-18 and/or S100 proteins (e.g., calprotectin) strongly supports the diagnosis and should be measured if available 1:
- These biomarkers are not yet universally available but represent the strongest supportive evidence when present 1
- IL-18 and S100 proteins show superior diagnostic accuracy compared to traditional markers 1
- The 2024 guidelines specifically recommend their measurement when accessible 1
Critical Differential Diagnoses to Exclude
Before confirming Still's disease, systematically rule out 1:
Infectious Causes
- Viral syndromes (rubella, CMV, EBV, mumps, Coxsackievirus, adenovirus) 1
- If symptoms persist beyond 3 months, viral causes become less likely 1
- Bacterial infections including mycobacteria 1
Neoplastic Disorders
- Leukemia, lymphoma, angioblastic lymphadenopathy 1
- These may present with atypical rashes or isolated lymphadenopathy 1
- Bone marrow or lymph node biopsy may be needed in unclear cases 1
Autoinflammatory Syndromes
- Familial Mediterranean fever (FMF) 1
- TNF receptor-associated periodic syndrome (TRAPS) 1
- Other periodic fever syndromes 1
Other Rheumatic Diseases
Diagnostic Algorithm
- Identify the four cardinal features using operational definitions above 1
- Apply Yamaguchi criteria to support clinical diagnosis 1
- Measure IL-18 and S100 proteins if available for strong supportive evidence 1
- Systematically exclude infectious, neoplastic, and other autoimmune causes 1, 2
- Do NOT delay diagnosis waiting for arthritis to develop 1
Common Diagnostic Pitfalls
- Waiting for arthritis to appear: This causes unnecessary diagnostic delays and is explicitly discouraged by the 2024 guidelines 1
- Missing the rash on darker skin: Requires heightened clinical awareness 1
- Performing unnecessary exploratory laparotomy: The constellation of fever, abdominal pain, and mesenteric lymphadenopathy can mimic surgical emergencies 1
- Overlooking periodic fever syndromes: These can closely mimic Still's disease, particularly in younger patients 1
Disease Activity and Remission Definitions
Once diagnosed, use these standardized definitions 1:
- Clinically inactive disease (CID): Absence of Still's disease-related symptoms AND normal ESR or CRP 1
- Remission: Period of at least 6 months with CID 1
Life-Threatening Complication Requiring Vigilance
Macrophage activation syndrome (MAS) occurs in up to 23% of patients and represents the most severe complication with high mortality 3, 4: